You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adenocarcinoma of the pancreas

Showing 1 - 25 of 3,678
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of

Completed
  • Pancreas Cancer
    • (no location specified)
    Jul 15, 2023

    Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma Trial in Saint Louis (device, drug, procedure)

    Recruiting
    • Pancreas Cancer
    • +2 more
    • MR-guided stereotactic body radiation therapy
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 29, 2023

    Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

    Not yet recruiting
    • Metastatic Pancreatic Adenocarcinoma
    • Ann Arbor, Michigan
      Rogel Cancer Center
    Jun 26, 2023

    Pancreas Cancer, Pancreas Adenocarcinoma Trial in Cleveland (Capecitabine)

    Not yet recruiting
    • Pancreas Cancer
    • Pancreas Adenocarcinoma
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Seidman Cancer Ce
    Oct 29, 2023

    Metastatic Adenocarcinoma of the Pancreas Trial in Soeul (Minnelide)

    Recruiting
    • Metastatic Adenocarcinoma of the Pancreas
    • Minnelide
    • Soeul, Korea, Republic of
      Samsung Medical Center
    Dec 8, 2022

    Pancreatic Ductal Adenocarcinoma, Pancreas Adenocarcinoma, Pancreas Cancer Trial in Kansas City (Enfortumab vedotin)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +2 more
    • Enfortumab vedotin
    • Kansas City, Kansas
      University of Kansas Cancer Center
    Jun 23, 2023

    Cancer of Pancreas, Chemo Effect, Metastatic Pancreatic Cancer Trial in Shibin Al Kawm (Gemcitabine fluorouracil)

    Completed
    • Cancer of Pancreas
    • +2 more
    • Gemcitabine fluorouracil
    • Shibīn Al Kawm, Menoufia, Egypt
      Menoufia University, Faculty of medicine
    Aug 5, 2022

    Chemo Effect, Pancreas Cancer Trial in Barcelona (Neoadyuvant therapy)

    Not yet recruiting
    • Chemotherapy Effect
    • Pancreas Cancer
    • Neoadyuvant therapy
    • Barcelona, Spain
      Hospital del Mar
    Aug 23, 2022

    Pancreas Adenocarcinoma Trial in Suwon (Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts

    Recruiting
    • Pancreas Adenocarcinoma
    • Pancreatic ductal adenocarcinoma organoids and cancer-associated fibroblasts establishment group
    • Suwon, Gyeong Gi Do, Korea, Republic of
      Ajou University Hospital
    Oct 7, 2022

    Adenocarcinoma of the Pancreas Trial in Miami (Durvalumab, Radiation Therapy)

    Active, not recruiting
    • Adenocarcinoma of the Pancreas
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Jul 7, 2022

    Cancer Of Pancreas Trial (Analyze of GemCore status)

    Not yet recruiting
    • Cancer Of Pancreas
    • Analyze of GemCore status
    • (no location specified)
    Sep 19, 2023

    Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

    Recruiting
    • Pancreatic Cancer
    • +2 more
    • New York, New York
    • +1 more
    Nov 7, 2022

    Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)

    Active, not recruiting
    • Pancreatic Cancer
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center
    Jan 5, 2023

    Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

    Not yet recruiting
    • Pancreas Adenocarcinoma
    • +2 more
    • Nab paclitaxel
    • +3 more
    • Winston-Salem, North Carolina
      Wake Forest Baptist Comprehensive Cancer Center
    Apr 19, 2023

    Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be

    Recruiting
    • Ductal Adenocarcinoma of the Pancreas
    • Whipple over the splenic artery
    • Total pancreatectomy
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 1, 2023

    Survival, Quality of Life and Resectability in Locally Advanced

    Recruiting
    • Pancreas Cancer
    • +8 more
      • Umeå, Sweden
        Surgical Clinic at Umeå University Hospital
      Nov 23, 2022

      Predict Lymphovascular Invasion in Pancreatic Ductal

      Recruiting
      • Predictive Cancer Model
      • Pancreas Cancer
        • Tianjin, Tianjin, China
          Tianjin Medical University Cancer Institute and Hospital
        Aug 10, 2023

        18F-FAPI, 18F-FDG, Pancreas Adenocarcinoma Trial in Hangzhou (18F-FAPI, 18F-FDG)

        Completed
        • 18F-FAPI
        • +4 more
        • Hangzhou, Zhejiang, China
          the First Affiliated Hospital, School of Medicine, Zhejiang Univ
        May 31, 2023

        Pancreatic Ductal Adenocarcinoma Trial in Durham (HA Chemotherapy)

        Not yet recruiting
        • Pancreatic Ductal Adenocarcinoma
        • HA Chemotherapy
        • Durham, North Carolina
          Duke University Health System
        Nov 22, 2022

        Improving Pancreatic Cancer Care by Use of Computational Science

        Recruiting
        • Pancreatic Cancer
        • +5 more
        • No interventions
        • Utrecht, Netherlands
          Regional Academic Cancer Center Utrecht
        Sep 22, 2023

        Adenocarcinoma of the Pancreas, Adenocarcinoma of the Duodenum, Ampullary Adenocarcinoma Trial in Lille (total pancreatectomy,

        Recruiting
        • Adenocarcinoma of the Pancreas
        • +2 more
        • total pancreatectomy
        • intraportal islet autotransplantation
        • Lille, France
          Hop Claude Huriez Chu Lille
        Mar 14, 2022

        Metastatic Pancreatic Adenocarcinoma Trial in Baltimore (Epacadostat, Pembrolizumab, CRS-207)

        Active, not recruiting
        • Metastatic Pancreatic Adenocarcinoma
        • Baltimore, Maryland
          The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
        Jan 3, 2023

        Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

        Recruiting
        • Untreated Resectable Pancreatic Adenocarcinoma
        • +2 more
        • Paclitaxel protein bound
        • +3 more
        • Scottsdale, Arizona
          HonorHealth Research Institute
        May 10, 2022

        Pancreas Cancer, Gastrointestinal Adenocarcinoma Trial in New York (ultrasound)

        Recruiting
        • Pancreas Cancer
        • Gastrointestinal Adenocarcinoma
        • ultrasound
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        May 12, 2022